PH25465A - Unsaturated phosphonic acids, derivatives - Google Patents

Unsaturated phosphonic acids, derivatives

Info

Publication number
PH25465A
PH25465A PH36083A PH36083A PH25465A PH 25465 A PH25465 A PH 25465A PH 36083 A PH36083 A PH 36083A PH 36083 A PH36083 A PH 36083A PH 25465 A PH25465 A PH 25465A
Authority
PH
Philippines
Prior art keywords
carbon
carboxyl
derivatives
compounds
membered ring
Prior art date
Application number
PH36083A
Inventor
Alan J Hutchison
Kenneth R Shaw
Josef A Schneider
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH25465A publication Critical patent/PH25465A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compounds of the formula I <IMAGE> in which one or both of the acidic hydroxyl groups of the phosphonic acid part can be etherified, m is one or zero, R<1> denotes carboxyl, esterified carboxyl or amidated carboxyl, the heterocyclic five- or six-membered ring can additionally be substituted on the carbon and/or nitrogen, can have a carbon-carbon double bond or can be condensed with a carbocyclic 6-membered ring, starting from adjacent carbon atoms, A represents lower alkenylene; and salts thereof. These compounds are suitable as antagonists of the N-methyl-D-aspartate- sensitive amino acid stimulant receptor in mammals.
PH36083A 1986-11-21 1987-11-18 Unsaturated phosphonic acids, derivatives PH25465A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93370286A 1986-11-21 1986-11-21

Publications (1)

Publication Number Publication Date
PH25465A true PH25465A (en) 1991-07-01

Family

ID=25464377

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36083A PH25465A (en) 1986-11-21 1987-11-18 Unsaturated phosphonic acids, derivatives

Country Status (21)

Country Link
EP (1) EP0275820B1 (en)
JP (1) JPH0686470B2 (en)
KR (1) KR880006195A (en)
AT (1) ATE60776T1 (en)
AU (1) AU610841B2 (en)
CA (1) CA1312608C (en)
DD (1) DD273837A5 (en)
DE (1) DE3768000D1 (en)
DK (1) DK609487A (en)
ES (1) ES2031927T3 (en)
FI (1) FI86638C (en)
GR (1) GR3001443T3 (en)
HU (1) HU199857B (en)
IE (1) IE60534B1 (en)
IL (1) IL84492A0 (en)
MX (1) MX9437A (en)
NO (1) NO170853C (en)
NZ (1) NZ222607A (en)
PH (1) PH25465A (en)
PT (1) PT86168B (en)
ZA (1) ZA878699B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
SE9003652D0 (en) * 1990-11-15 1990-11-15 Astra Ab NEW HETEROCYCLIC COMPOUNDS
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
AU742293B2 (en) 1997-06-12 2001-12-20 Aventis Pharma Limited Imidazolyl-cyclic acetals
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives

Also Published As

Publication number Publication date
NO170853B (en) 1992-09-07
FI86638C (en) 1992-09-25
GR3001443T3 (en) 1992-09-25
EP0275820A3 (en) 1988-08-03
CA1312608C (en) 1993-01-12
NO874854D0 (en) 1987-11-20
ZA878699B (en) 1988-05-23
MX9437A (en) 1994-01-31
DD273837A5 (en) 1989-11-29
DE3768000D1 (en) 1991-03-14
AU610841B2 (en) 1991-05-30
HU199857B (en) 1990-03-28
DK609487A (en) 1988-05-22
NO874854L (en) 1988-05-24
ES2031927T3 (en) 1993-01-01
EP0275820A2 (en) 1988-07-27
ATE60776T1 (en) 1991-02-15
NO170853C (en) 1992-12-16
AU8145587A (en) 1988-05-26
JPH0686470B2 (en) 1994-11-02
IE873149L (en) 1988-05-21
FI86638B (en) 1992-06-15
IL84492A0 (en) 1988-04-29
FI875097A7 (en) 1988-05-22
JPH01135791A (en) 1989-05-29
PT86168A (en) 1987-12-01
EP0275820B1 (en) 1991-02-06
IE60534B1 (en) 1994-07-27
PT86168B (en) 1990-08-31
DK609487D0 (en) 1987-11-20
KR880006195A (en) 1988-07-22
HUT46331A (en) 1988-10-28
FI875097A0 (en) 1987-11-18
NZ222607A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
PT82626A (en) Process for preparing ceryain phosphonil acids and derivatives thereof
EP0275820A3 (en) Unsaturated phosphonic acids and derivatives
FI881892A0 (en) Process for the preparation of new therapeutically useful 1,2,5,6-tetrahydropyridine derivatives
ES2024024B3 (en) CORROSION INHIBITING COMPOSITION.
SE8200570L (en) TIAZOLIDE INGREDIENTS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR PREPARING THEREOF
AU584336B2 (en) New cephalosporins and processes for their preparation
ES2076369T3 (en) PROCEDURE FOR THE SEPARATION OF RACEMATES OF ESTERS OF 4-ARYL-2-OXO-PIRROLIDINE-3-CARBOXYLIC ACIDS.
ES2053868T3 (en) 3-AMINOSIDNONIMINAS SUBSTITUTED, PROCEDURES FOR ITS OBTAINING AND ITS EMPLOYMENT.
ES2000369A6 (en) Substituted DI-t-butylphenols.
DK161090A (en) NEW TOPICAL PREPARATION FOR THE TREATMENT OF ALOPECI